Healthcare provider profile · identity verified

Mina Gohari, M.D.

Family Practice · SALT LAKE CITY, UT · NPI 1083824940

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	624	182
Levothyroxine Sodium	Levothyroxine Sodium	591	169
Amlodipine Besylate	Amlodipine Besylate	588	171
Omeprazole	Omeprazole	453	135
Losartan Potassium	Losartan Potassium	438	131
Alendronate Sodium	Alendronate Sodium	428	140
Simvastatin	Simvastatin	381	112
Lisinopril	Lisinopril	319	95
Sertraline Hcl	Sertraline Hcl	277	88
Hydrochlorothiazide	Hydrochlorothiazide	209	65
Trazodone Hcl	Trazodone Hcl	202	56
Gabapentin	Gabapentin	200	73
Rosuvastatin Calcium	Rosuvastatin Calcium	193	64
Metformin Hcl	Metformin Hcl	192	61
Metoprolol Succinate	Metoprolol Succinate	183	55
Duloxetine Hcl	Duloxetine Hcl	136	37
Potassium Chloride	Potassium Chloride	132	45
Tamsulosin Hcl	Tamsulosin Hcl	115	34
Furosemide	Furosemide	109	40
Pantoprazole Sodium	Pantoprazole Sodium	109	33
Eliquis	Apixaban	102	34
Escitalopram Oxalate	Escitalopram Oxalate	101	33
Donepezil Hcl	Donepezil Hcl	100	27
Irbesartan	Irbesartan	100	37
Carvedilol	Carvedilol	98	30
Glipizide	Glipizide	92	22
Hydralazine Hcl	Hydralazine Hcl	86	21
Tramadol Hcl	Tramadol Hcl	86	16
Montelukast Sodium	Montelukast Sodium	84	21
Oxybutynin Chloride Er	Oxybutynin Chloride	82	26
Allopurinol	Allopurinol	79	27
Albuterol Sulfate Hfa	Albuterol Sulfate	76	37
Spironolactone	Spironolactone	75	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	21
Metformin Hcl Er	Metformin Hcl	74	26
Pravastatin Sodium	Pravastatin Sodium	74	22
Zolpidem Tartrate	Zolpidem Tartrate	67	16
Glipizide Er	Glipizide	66	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	14
Citalopram Hbr	Citalopram Hydrobromide	64	18
Lorazepam	Lorazepam	62	18
Synthroid	Levothyroxine Sodium	62	17
Buspirone Hcl	Buspirone Hcl	61	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	14
Fluoxetine Hcl	Fluoxetine Hcl	60	18
Clonazepam	Clonazepam	58	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	15
Memantine Hcl	Memantine Hcl	51	14
Myrbetriq	Mirabegron	47	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	15
Metoprolol Tartrate	Metoprolol Tartrate	46	13
Mirtazapine	Mirtazapine	43	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	38
Symbicort	Budesonide/Formoterol Fumarate	43	11
Bupropion Xl	Bupropion Hcl	42	11
Celecoxib	Celecoxib	41	24
Fluticasone Propionate	Fluticasone Propionate	40	13
Atenolol	Atenolol	39	11
Ondansetron Hcl	Ondansetron Hcl	39	13
Lovastatin	Lovastatin	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	12
Ezetimibe	Ezetimibe	37	12
Ibandronate Sodium	Ibandronate Sodium	36	12
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Ramipril	Ramipril	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	11
Azithromycin	Azithromycin	32	30
Acyclovir	Acyclovir	31	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	11
Finasteride	Finasteride	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Alprazolam	Alprazolam	29	suppressed
Famotidine	Famotidine	29	13
Prednisone	Prednisone	29	25
Jardiance	Empagliflozin	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	25	suppressed
Cephalexin	Cephalexin	24	17
Estradiol	Estradiol	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	13
Mounjaro	Tirzepatide	23	11
Verapamil Er	Verapamil Hcl	23	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Nystatin	Nystatin	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Prolia	Denosumab	18	12
Sucralfate	Sucralfate	18	suppressed
Torsemide	Torsemide	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluconazole	Fluconazole	16	13
Trulicity	Dulaglutide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Valsartan	Valsartan	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cartia Xt	Diltiazem Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Nucynta Er	Tapentadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error